C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses.
Baraldo
M
M
Department of Pharmacology, School of Medicine, University of Udine, Udine, Italy. massimo.baraldo@dpmsc.uniud.it
Francesconi
A
A
Barbone
F
F
Tursi
V
V
Livi
U
U
Furlanut
M
M
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D008875:Middle Aged; D015203:Reproducibility of Results
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine